Profil
Daniel Kaplan is currently the Chief Scientific Officer at NGM Biopharmaceuticals, Inc. He started this position in 2023.
Prior to his current role, he obtained a doctorate degree from Duke University and an undergraduate degree from the University of California San Diego.
Aktiva positioner av Daniel Kaplan
| Företag | Position | Start |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-04-01 |
Daniel Kaplans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















